Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2002
08/08/2002WO2002061115A2 Method for the evolutionary design of biochemical reaction networks
08/08/2002WO2002061113A2 Nucleic acid derived vaccine that encodes an antigen linked to a polypeptide that promotes antigen presentation
08/08/2002WO2002061110A2 Nucleic acid derivatives
08/08/2002WO2002061109A2 Yeast strains autonomously producing steroids
08/08/2002WO2002061108A2 Microorganisms and processes for enhanced production of pantothenate
08/08/2002WO2002061106A2 Method for producing cysteine, cystine and glutathione by fermentation
08/08/2002WO2002061105A2 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc)
08/08/2002WO2002061104A2 Hybrid adenoviral vector
08/08/2002WO2002061103A1 Method for obtaining packaging cells producing retrovirus by eliminating cells liable to be infected by the retrovirus produced
08/08/2002WO2002061102A2 Control of gene expression in plants
08/08/2002WO2002061101A2 Method of imparting disease resistance to plants by reducing polyphenol oxidase activity
08/08/2002WO2002061100A1 Expression of multiple proteins in transgenic plants
08/08/2002WO2002061099A1 Control of bacterial infection by quenching quorum-sensing of plant pathogenic bacteria
08/08/2002WO2002061098A2 Promoters from cyanobacteria allowing high expression levels
08/08/2002WO2002061097A1 Cloning vectors and vector components
08/08/2002WO2002061096A1 Determination of hydrophobic coenzyme a esters and other lipids using a biosens or comprising a modified coenzyme a- and acyl- binding protein (acbp)
08/08/2002WO2002061095A1 Novel protein and dna thereof
08/08/2002WO2002061094A2 Microbiological method for producing l-carnitine
08/08/2002WO2002061093A1 Nucleotide sequences which code for the otsa gene of c. glutamicum
08/08/2002WO2002061092A2 Regulation of human lysyl oxidase
08/08/2002WO2002061091A1 Expression facilitating nucleotide sequences for hemoglobin receptor activity from porphyromonas gingivalis
08/08/2002WO2002061090A2 Prokaryotically produced antibodies and uses thereof
08/08/2002WO2002061089A2 Crystallized hnf4 gamma ligand binding domain polypeptide and screening methods employing same
08/08/2002WO2002061088A2 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
08/08/2002WO2002061087A2 Antigenic peptides, such as for g protein-coupled receptors (gpcrs), antibodies thereto, and systems for identifying such antigenic peptides
08/08/2002WO2002061086A2 Human leucine-rich repeat containing protein expressed predominately in small intestine, hlrrsi1
08/08/2002WO2002061085A2 Isolated genomic polynucleotide fragments from the p15 region of chromosome 11
08/08/2002WO2002061084A2 Nt69, a nucleoside transporter family member and uses therefor
08/08/2002WO2002061083A1 Novel g protein-coupled receptor protein and dna thereof
08/08/2002WO2002061082A2 Zis-sr nucleic acid and amino acid sequences involved in the regulated secretory pathway and/or the regulation of the neuroendocrine phenotype (nep)
08/08/2002WO2002061081A1 A novel gene bn01 mapping to chromosome 16q24.3
08/08/2002WO2002061080A1 Novel translational activity-promoting higher-order structure
08/08/2002WO2002061079A2 Biligands
08/08/2002WO2002061078A2 Streptavidin aptamere
08/08/2002WO2002061075A1 Novel g protein-coupled receptor protein and dna thereof
08/08/2002WO2002061073A2 Mutwnt fish for genetic screebibg of lipid and cholesterol metabolism
08/08/2002WO2002061072A2 Transgenic plants containing altered levels of steroid compounds
08/08/2002WO2002061071A2 Focused libraries of genetic packages
08/08/2002WO2002061070A2 Environmentally regulated genes, involved in the virulence of streptococcus suis
08/08/2002WO2002061069A1 Runx3 gene showing anti-tumor activity and use thereof
08/08/2002WO2002061064A2 Method for producing recombinant trypsin
08/08/2002WO2002061062A2 Human protein kinase n-like polypeptide and uses thereof
08/08/2002WO2002061058A2 Regulation of human phospholipase
08/08/2002WO2002061056A2 Degp2 protease that degrades photo-damaged d1 protein and a dna sequence that codes for said protease
08/08/2002WO2002061050A2 Methods for determining ring number in carotenoids by lycopene epsilon-cyclases and uses thereof
08/08/2002WO2002061048A2 In vitro system for replication of rna-dependent rna polymerase (rdrp) viruses
08/08/2002WO2002061046A2 Novel nucleic acid and polypeptide molecules
08/08/2002WO2002061045A2 Simplified method for indexing and determining the relative concentration of expressed messenger rnas
08/08/2002WO2002061043A2 Fungal resistant transgenic plants
08/08/2002WO2002061042A2 Genetic control of organ abscission
08/08/2002WO2002061041A2 Solubility reporter gene constructs
08/08/2002WO2002061040A2 Gene delivery formulations and methods for treatment of ischemic conditions
08/08/2002WO2002061039A2 Thuja plicata dirigent protein promotors
08/08/2002WO2002061038A2 Homo-doubly labeled compositions for the detection of enzyme activity in biological samples
08/08/2002WO2002061037A2 Administration of nucleic acid sequence to female animal
08/08/2002WO2002061034A2 Compositions and methods for rapidly generating recombinant nucleic acid molecules
08/08/2002WO2002061033A2 Transfection of human embryonic stem cells
08/08/2002WO2002060974A1 Polymers
08/08/2002WO2002060955A2 Modified antibodies and methods of use
08/08/2002WO2002060952A1 Serpin variants and uses thereof
08/08/2002WO2002060951A2 Methods and compositions for reducing heparan sulfate proteoglycan-mediated clearance of factor viii
08/08/2002WO2002060950A2 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
08/08/2002WO2002060949A2 Glycoforms a fas ligand inhibitory protein analog
08/08/2002WO2002060948A1 Novel g protein-coupled receptor protein and dna thereof
08/08/2002WO2002060945A2 Human ion channel protein and polynucleotides encoding the same
08/08/2002WO2002060943A1 Human mitochondrial proteins and polynucleotides encoding the proteins
08/08/2002WO2002060942A2 Protein modification and maintenance molecules
08/08/2002WO2002060941A2 Fluorescent proteins
08/08/2002WO2002060940A1 Juvenile hormone esterase
08/08/2002WO2002060939A2 Method for increasing the sulphur-compound content in plants
08/08/2002WO2002060938A2 Haemophilus influenza basb212 polynucleotides, polypeptides and use thereof
08/08/2002WO2002060937A1 Universal carrier for targeting molecules to gb3 receptor expressing cells
08/08/2002WO2002060936A2 Vaccine and compositions for the prevention and treatment of neisserial infections
08/08/2002WO2002060935A2 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences
08/08/2002WO2002060934A2 IDENTIFICATION OF THE ANTI-σ28 FACTOR IN HELICOBACTER PYLORI, IN CAMPYLOBACTER JEJUNI AND IN PSEUDOMONAS AERUGINOSA AND APPLICATION THEREOF
08/08/2002WO2002060932A2 A serpin in bifidobacteria
08/08/2002WO2002060931A2 A fimbria-like gene in bifidobacteria
08/08/2002WO2002060929A2 Polymer conjugates of neublastin and methods of using same
08/08/2002WO2002060928A2 Medane genes and proteins
08/08/2002WO2002060924A2 Identification and applications of porcine reproductive and respiratory syndrome virus host susceptibility factor(s) for improved swine breeding and development of a non-simian recombinant cell line for propagation of the virus and a target for a novel class of antiviral compounds
08/08/2002WO2002060923A2 B-superfamily conotoxins
08/08/2002WO2002060919A2 Molecules with extended half-lives, compositions and uses thereof
08/08/2002WO2002060914A2 Identification of small rnas and orfs form e. coli as mediators of cell and intercell regulation
08/08/2002WO2002060584A2 Method for carrying out a biochemical protocol in continuous flow in a microreactor
08/08/2002WO2002060553A1 Isolation of nanoparticles
08/08/2002WO2002060492A1 Methods of inhibiting kinases
08/08/2002WO2002060490A1 Retroviral vector
08/08/2002WO2002060477A1 Scaffolded fusion polypeptides, compositions for making the same and methods of using the same
08/08/2002WO2002060467A2 Compositions and methods for improving kidney function
08/08/2002WO2002060386A2 METHODS OF TREATING INFLAMMATORY AND IMMUNE DISEASES USING INHIBITORS OF IλB KINASE (IKK)
08/08/2002WO2002060376A2 Induction of tolerance by apoptotic and/or necrotic cells
08/08/2002WO2002060340A2 Method for identifying maxi-k channel blockers
08/08/2002WO2002060318A2 Detection of methylated cpg rich sequences diagnostic for malignant cells
08/08/2002WO2002046208A3 Method of producing biospecific molecules by protein trans-splicing
08/08/2002WO2002042441A3 VON WILLEBRAND FACTOR (vWF) CLEAVING PROTEASE POLYPEPTIDE, NUCLEIC ACID ENCODING THE POLYPEPTIDE AND USE OF POLYPEPTIDE
08/08/2002WO2002038597A3 Genomic fragment of streptococcus suis and clinical uses thereof
08/08/2002WO2002036736A3 Alpha-tocopherol transfer protein knockout animals
08/08/2002WO2002034945A3 Estrogen receptor alpha variants and methods of detection thereof
08/08/2002WO2002034903A3 Nucleic acid generating the abca7 gene, molecules modulating its activity and therapeutic applications
08/08/2002WO2002034881A3 Compositions and methods for the discovery and selection of biological information